Certain populations have been historically underrepresented in genome sequencing studies, but the NIH, private clinics, and 23andMe and other companies are trying to fix that.

The publication of the SCIPIO trial is among many by Piero Anversa’s lab that Harvard Medical School flagged for fraudulent data.

A government scientist, he tried to end the unethical study, was unsuccessful, and then spent his career combatting injustice in healthcare.

The manuscript had amassed more than 50 comments about problematic figures and data on PubPeer.

A recent meeting about the disconnect between scientific and public beliefs points to ways researchers can improve how they communicate with skeptics.

Information made public by US Senator Chuck Grassley reveals that a handful of allegations have recently been referred to federal investigators.

Wong Chi-huey, who was the president of Academia Sinica until 2016, was found not guilty of taking bribes from a pharmaceutical company.

Scientists are working to maximize the benefits and minimize the costs of sharing.

From a self-sampling scientist to the downfall of a leading stem cell scientist, here’s our naughty list.